Clinical Trial Update: Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating an HDM1005 injection for obesity in adults without diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HDM1005

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Obesity | Phase 2 | Status: RECRUITING